MARKET

SRTS

SRTS

Sensus Hlthcr
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.620
+0.080
+3.15%
Closed 16:00 09/25 EDT
OPEN
2.530
PREV CLOSE
2.540
HIGH
2.700
LOW
2.430
VOLUME
10.04K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
1.760
MARKET CAP
43.24M
P/E (TTM)
-7.3761
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Is Sensus Healthcare, Inc. (NASDAQ:SRTS) Trading At A 46% Discount?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Sensus Healthcare...
Simply Wall St. · 09/08 20:45
Sensus Healthcare EPS beats by $0.01, misses on revenue
Sensus Healthcare (NASDAQ:SRTS): Q2 GAAP EPS of -$0.16 beats by $0.01. Revenue of $1.18M (-84.2% Y/Y) misses by $0.96M. Press Release
seekingalpha · 08/07 01:10
Sensus Healthcare Reports Second Quarter 2020 Financial Results
Conference call begins at 4:30 p.m. Eastern time todayBOCA RATON, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective tre
GlobeNewswire · 08/06 20:02
American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units
Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systemsBOCA RATON, Fla, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specia
GlobeNewswire · 08/05 12:30
Sensus high on mobile aesthetic laser companies acquisition
In all-cash transactions, Sensus Healthcare (SRTS +10.3%) acquired two Florida-based mobile aesthetic laser companies - Aesthetic Mobile Laser Services and
seekingalpha · 08/04 20:29
Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies In Florida
Benzinga · 08/04 12:42
Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida
* Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the state * Expected to add $1.0 million in revenues over the next 12 months and to be immediately accretive to earnings * Management
GlobeNewswire · 08/04 12:30
Sensus Healthcare to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 6, 2020
BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will
GlobeNewswire · 07/30 12:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRTS. Analyze the recent business situations of Sensus Hlthcr through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRTS stock price target is 5.07 with a high estimate of 6.00 and a low estimate of 4.250.
EPS
Institutional Holdings
Institutions: 29
Institutional Holdings: 1.69M
% Owned: 10.25%
Shares Outstanding: 16.50M
TypeInstitutionsShares
Increased
2
56.11K
New
7
-254.44K
Decreased
3
40.41K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.83%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/President/Chief Executive Officer/Co-Founder/Director
Joseph Sardano
Co-Founder/Executive Vice President
Stephen Cohen
Chief Financial Officer
Javier Rampolla
Chief Operating Officer
Nicolas Soro
Chief Technology Officer
James Price
Vice President/General Counsel
Michael Sardano
Vice President/Director of Sales
Hoi-Bun Suen
Non-Executive Director
Anthony Petrelli
Non-Executive Independent Director
John Heinrich
Non-Executive Independent Director
William McCall
Non-Executive Independent Director
Samuel O'Rear
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. It uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. The Company's product, the SRT-100, is a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions in the sensitive areas of the head and neck region. Its Sensus Laser Aesthetic Solutions division provides a range of in-office aesthetic dermatology procedures including facial rejuvenation, wrinkle removal, body sculpting/fat removal as well as other aesthetic applications.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Sensus Healthcare Inc stock information, including NASDAQ:SRTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRTS stock methods without spending real money on the virtual paper trading platform.